These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8060993)

  • 41. Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers.
    Capranico G; Tinelli S; Zunino F; Kohn KW; Pommier Y
    Biochemistry; 1993 Jan; 32(1):145-52. PubMed ID: 8380330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Base mutation analysis of topoisomerase II-idarubicin-DNA ternary complex formation. Evidence for enzyme subunit cooperativity in DNA cleavage.
    Bigioni M; Zunino F; Capranico G
    Nucleic Acids Res; 1994 Jun; 22(12):2274-81. PubMed ID: 8036155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.
    Yamashita Y; Kawada S; Fujii N; Nakano H
    Biochemistry; 1991 Jun; 30(24):5838-45. PubMed ID: 1646001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage.
    Capranico G; Palumbo M; Tinelli S; Mabilia M; Pozzan A; Zunino F
    J Mol Biol; 1994 Jan; 235(4):1218-30. PubMed ID: 8308885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deletion and duplication sequences induced in CHO cells by teniposide (VM-26), a topoisomerase II targeting drug, can be explained by the processing of DNA nicks produced by the drug-topoisomerase interaction.
    Ripley LS
    Mutat Res; 1994 Apr; 312(2):67-78. PubMed ID: 7510833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin.
    Bailly C; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M; Waring MJ
    Mol Pharmacol; 1998 Jan; 53(1):77-87. PubMed ID: 9443934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.
    Oppegard LM; Ougolkov AV; Luchini DN; Schoon RA; Goodell JR; Kaur H; Billadeau DD; Ferguson DM; Hiasa H
    Eur J Pharmacol; 2009 Jan; 602(2-3):223-9. PubMed ID: 19071108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety.
    Capranico G; Butelli E; Zunino F
    Cancer Res; 1995 Jan; 55(2):312-7. PubMed ID: 7812964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, DNA and protein interactions and human topoisomerase inhibition of novel Spiroacridine derivatives.
    Gouveia RG; Ribeiro AG; Segundo MÂSP; de Oliveira JF; de Lima MDCA; de Lima Souza TRC; de Almeida SMV; de Moura RO
    Bioorg Med Chem; 2018 Dec; 26(22):5911-5921. PubMed ID: 30420325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
    Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
    Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
    Pommier Y; Orr A; Kohn KW; Riou JF
    Cancer Res; 1992 Jun; 52(11):3125-30. PubMed ID: 1317259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topoisomerase II-mediated DNA cleavage: evidence for distinct regions of enzyme-DNA contacts.
    Alsner J; Sorensen HV; Schmidt VK; Sorensen BS; Westergaard O
    J Mol Biol; 1996 Jun; 259(3):317-24. PubMed ID: 8676370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA abasic lesions in a different light: solution structure of an endogenous topoisomerase II poison.
    Cline SD; Jones WR; Stone MP; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15500-7. PubMed ID: 10569932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon.
    Nahon E; Best-Belpomme M; Saucier JM
    Eur J Biochem; 1993 Nov; 218(1):95-102. PubMed ID: 8243480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of DNA intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-aminoacridines.
    Pommier Y; Covey J; Kerrigan D; Mattes W; Markovits J; Kohn KW
    Biochem Pharmacol; 1987 Oct; 36(20):3477-86. PubMed ID: 2823823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds.
    Janočková J; Plšíková J; Kašpárková J; Brabec V; Jendželovský R; Mikeš J; Kovaľ J; Hamuľaková S; Fedoročko P; Kuča K; Kožurková M
    Eur J Pharm Sci; 2015 Aug; 76():192-202. PubMed ID: 25960253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine.
    Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK
    Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of topoisomerase II-mediated DNA cleavage by an indazole analogue of lucanthone.
    Dassonneville L; Bailly C
    Biochem Pharmacol; 1999 Oct; 58(8):1307-12. PubMed ID: 10487533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.